MédiMabs Clones
A blog about science

A potential target to stop Zika from replicating
Zika virus outbreak is a global emergency since 2016. A recent publication from Anton et al. 2021, has set in evidence some vulnerabilities that could be targeted. In their study they have asked us for a custom antibody project to allow them to study one of their proteins of interest.
Latest articles
TDP-43 targeted therapeutic approaches for ALS
MediMabs would like to congratulate for their recent publication (Pozzi et al. 2019 JCI) and highlight the work of Dr. Julien, Dr....
MédiMabs’ Team • Feb 28 • 5 minutes read
Valentine’s day dimers
When one and one make two. Dimerization is an important process in biology and especially in signal transduction. Receptor tyrosine kinases...
MédiMabs’ Team • Feb 14 • 2 minutes read
Happy new year and MIMs meeting
Another great occasion to discuss about immunology in Montreal organized by the (Montreal Immunology Meeting) MIM committee. We hope to meet you...
MédiMabs’ Team • Jan 31 • 1 minutes read
Which FGFR isoform drives cancer?
The promise of FGFR inhibitors in the clinic, but which FGFR isoform drives cancer?Urothelial cancer (UC) is the fifth most...
MédiMabs’ Team • Jan 31 • 5 minutes read
Angiogenesis in cancer, role of Endoglin (CD105)
When tumor cells are too far from blood supply, the different signals associated with hypoxia will be emitted. This will...
MédiMabs’ Team • Dec 06 • 2 minutes read
Another great 5 à 7 of the Montreal Immunology Meetings yesterday.
Yesterday, the second 5 à 7 from the 2018-2019 season of the Montreal Immunology Meetings was held in downtown Montréal. Again it...
MédiMabs’ Team • Dec 06 • 1 minutes read
The budding yeast, a classic cell cycle regulation model
The budding yeast (Saccharomyces cerevisiae) model has shown to be a powerful tool to study eukaryotic cell cycle regulation. The...
MédiMabs’ Team • Nov 22 • 2 minutes read
New publication! MM-0015-P
The presence of extracellular amyloid-beta plaques and tau neurofibrillary tangles has been a key neuropathological signature of Alzheimer's disease (AD)...
MédiMabs’ Team • Nov 22 • 5 minutes read
Biotech-Connect show of the McGill Bellini Life Sciences Complex this Thursday November 8
Held at the Bellini building of the McGill Life Science Complex, this biotech-connect show is a good opportunity to ask...
MédiMabs’ Team • Nov 06 • 1 minutes read
TLR4, 20 years later
20 years ago, in 1998, two research groups, Bruce Beutler’s and Shizuo Akira’s, have identified TLR4 as the LPS (Lipopolysaccharide)...
MédiMabs’ Team • Oct 31 • 2 minutes read